An Open-Label Phase 1 Study to Examine the Effect of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2010
At a glance
- Drugs Fluconazole; Ivacaftor; Midazolam; Rosiglitazone
- Indications Anxiety disorders; Seizures; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 18 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 New trial record